In the words of renowned scientist Francis Collins, "Genomics promises to revolutionize the field of medicine by unlocking the mysteries of our genetic makeup." This powerful quote sets the tone for exploring the challenges and future of cancer pharmacogenetics, a field that holds immense potential in shaping the future of oncology treatment.
Cancer pharmacogenetics and personalized medicine are at the forefront of precision oncology, offering a new paradigm in cancer care. Through advances in genomic science and proteomics, clinicians can now develop companion diagnostics and targeted therapies that offer more precise treatment options tailored to an individual's genetic profile.
However, as we journey into this new era of medicine, we encounter several challenges that need to be addressed. Interindividual variability in drug exposure and the potential for under or overexposure to drugs are critical factors affecting the efficacy and s...
_____
If you are a member of our Association, please log in below to continue reading our exclusive content.
Not a member yet? Discover the benefits of joining our network and gain access to exclusive content like this for only $29.95 per month. Learn More and Sign Up
